0001920179-23-000003.txt : 20230111 0001920179-23-000003.hdr.sgml : 20230111 20230111153035 ACCESSION NUMBER: 0001920179-23-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Randall Mark Edward CENTRAL INDEX KEY: 0001916323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41231 FILM NUMBER: 23523521 MAIL ADDRESS: STREET 1: C/O RENAISSANCE CAPITAL PARTNERS LTD STREET 2: 42 SHAD THAMES CITY: LONDON STATE: X0 ZIP: SE1 2YD ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TC BioPharm (Holdings) plc CENTRAL INDEX KEY: 0001872812 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MAXIM 1 STREET 2: 2 PARKLANDS WAY CITY: HOLYTOWN STATE: X0 ZIP: ML1 4WR BUSINESS PHONE: 01414337557 MAIL ADDRESS: STREET 1: MAXIM 1 STREET 2: 2 PARKLANDS WAY CITY: HOLYTOWN STATE: X0 ZIP: ML1 4WR FORMER COMPANY: FORMER CONFORMED NAME: TC BioPharm (Holdings) Ltd DATE OF NAME CHANGE: 20210721 FORMER COMPANY: FORMER CONFORMED NAME: TC BioPharm Ltd DATE OF NAME CHANGE: 20210714 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-11-30 0 0001872812 TC BioPharm (Holdings) plc TCBP 0001916323 Randall Mark Edward C/O RENAISSANCE CAPITAL PARTNERS LTD 42 SHAD THAMES LONDON X0 SE1 2YD UNITED KINGDOM 0 0 1 0 Ordinary Shares [ADS] 2022-11-30 4 P 0 70000 5 A 382963 I By Renaissance Capital Partners Ltd Ordinary Shares [ADS] 9952 D Series A Warrants 5 2022-11-30 4 P 0 70000 0 A 2022-11-30 2028-05-30 Ordinary Shares 70000 70000 I By Renaissance Capital Partners Ltd Series B Warrants 5 2022-11-30 4 P 0 70000 0 A 2022-11-30 2025-05-30 Ordinary Shares 70000 70000 I By Renaissance Capital Partners Ltd Warrants 4.25 2022-04-11 2028-02-10 Ordinary Shares 106129 106129 I By Renaissance Capital Partners Ltd Series A Warrants were issued as a part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00. Series B Warrants were issued as a part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00. /s/ Thomas Nicholls 2023-01-11